DIO Corporation (KOSDAQ:039840)
South Korea · Delayed Price · Currency is KRW 18,100
+600 (3.43%)
At close: Feb 6, 2026
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 242.34 billion as of February 6, 2026. Its market cap has increased by 5.26% in one year.
Market Cap
242.34B
Enterprise Value
278.82B
Revenue
155.15B
Ranking
n/a
PE Ratio
41.18
Stock Price
18,100.00
Market Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 242.34B, an increase of 853.29%. That is a compound annual growth rate of 9.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 242.34B | 7.16% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.21T |
| Celltrion | 48.14T |
| ALTEOGEN | 19.31T |
| Sam Chun Dang Pharm. | 11.63T |
| Suheung | 249.07B |
| EASY BIO,Inc. | 248.78B |
| Daewon Pharmaceutical | 244.13B |
| HLB Therapeutics | 241.80B |